Imfinzi (durvalumab) - AstraZeneca
Imjudo (tremelimumab-actl) - AstraZeneca
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
rilvegostomig (AZD2936) - AstraZeneca
volrustomig (MEDI5752) - AstraZeneca
Orpathys (savolitinib) - AstraZeneca, Hutchmed
https://www.astrazeneca.com/media-centre/press-releases/2026/astrazeneca-to-showcase-phase-iii-data-at-asco-2026.html
 
May 22, 2026
 
Prev Next